# Zipnosis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zipnosis

- Industry: Healthcare IT
- Headquarters: Minneapolis, US
- Website: www.zipnosis.com
- Total disclosed funding: $22M
- Latest round: Series B (Aug 17, 2018)
- Investors on record: 7

## About

Zipnosis, Inc. is a healthcare technology company that specializes in providing AI-driven tools for patient engagement and streamlined healthcare delivery through its innovative care access platform.Zipnosis, Inc. is a Minneapolis-based company that was founded in 2008, focusing on transforming healthcare delivery by enhancing patient access to care. In May 2023, it was acquired by Florence Labs, Inc. from Bright Health Management, Inc. for an undisclosed amount. The company has completed a total of 8 deals, with its latest funding round being a Series B in which it raised USD 3.050 mn, bringing the total amount raised to USD 3.050 mn.Zipnosis offers Fabric, a comprehensive care access platform that features AI-driven tools to enhance patient engagement and streamline healthcare delivery. Key offerings include the AI Assistant, chat and conversational AI, symptom checkers, and triage and routing systems, ensuring efficient patient-provider interactions while minimizing readmission rates. Fabric serves various stakeholders, including health systems, hospitals, health plans, and employers, catering to patients across the United States, Canada, and select European countries.Zipnosis operates under a B2B revenue model, primarily partnering with healthcare organizations, health plans, and employers through subscription agreements. Clients pay recurring fees for access to the platform’s services, including the Digital Front Door® and Hybrid AI solutions, which are designed to improve operational efficiency and patient satisfaction. Customized pricing plans are available reflecting the diverse range of services offered, including virtual care and automated clinical protocols.Following its acquisition in May 2023, Zipnosis aims to expand its product offerings with synchronous and asynchronous virtual care solutions. This strategic direction aligns with Florence Labs, Inc.'s goals for broadening its services. The company is also exploring opportunities for market expansion into new regions, although specific geographical targets and timelines have not been detailed.

## Funding rounds

- Series B, Aug 17, 2018, $3M — Safeguard Scientifics, Ascension Ventures, Arthur Ventures, Waterline Ventures, Fairview Health Services
- Series A, Jan 4, 2016, $17M — Safeguard Scientifics, Ascension Ventures, Hyde Park Venture Partners, Arthur Ventures, Omphalos Venture Partners, Waterline Ventures, Fairview Health Services
- Seed, Nov 18, 2014, $1.5M — Arthur Ventures

## Investors

- Arthur Ventures (https://capitalatlas.ai/funds/arthur-ventures) — Seed, Series A, Series B
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series A, Series B
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series A, Series B
- Hyde Park Venture Partners (https://capitalatlas.ai/funds/hyde-park-venture-partners) — Series A
- Omphalos Venture Partners (https://capitalatlas.ai/funds/omphalos-venture-partners) — Series A
- Waterline Ventures (https://capitalatlas.ai/funds/waterline-ventures) — Series A, Series B
- Fairview Health Services — Series A, Series B